Monday, December 14, 2015
Fifty exceptional students and early career scientists (MS, PhD, postdoc) will be selected for this unique opportunity to interact with PepsiCo's R&D leadership, learn about their efforts to develop products rooted in science-based nutrition, and get an exclusive glimpse of how science has shaped their careers.
Wednesday, September 16, 2015 | 8:00 AM - 2:15 PM
Award Winner Bert Vogelstein (Johns Hopkins School of Medicine; Howard Hughes Medical Institute)
This symposium will honor Dr. Bert Vogelstein, the recipient of the 2015 Dr. Paul Janssen Award for Biomedical Research, in recognition of his role in characterizing the underlying mechanisms of cancer. Symposium registration is free. Advance registration is required.
Thursday, September 17, 2015 | 6:30 PM - 7:30 PM
Featuring: Mr. Ellis Rubinstein (NYAS Chief Executive Officer) and selected members of the Academy's Senior Staff
Please join us for the Academy’s 197th Annual Members Meeting, followed by a Welcome Reception in honor of our new Members. Learn about how your Academy is evolving to meet the many challenges ahead, then meet and mingle with fellow Academy Members.
Friday, September 18, 2015 | 8:30 AM - 4:30 PM
Speakers: George S. Bloom (University of Virginia), Peter Davies (Feinstein Institute for Medical Research), Marc I. Diamond (University of Texas Southwestern Medical Center), Michael Hutton (Eli Lilly and Company), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Hartmuth C. Kolb (Johnson & Johnson, Janssen R&D), Nicole Leclerc (Université de Montréal), Kun Ping Lu (Harvard Medical School), Richard M. Ransohoff (Biogen)
Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.
Tuesday, September 29, 2015 | 12:00 PM - 5:00 PM
Speakers: Samie R. Jaffrey (Weill Cornell Medical College), Amy E. Palmer (University of Colorado)
This symposium features state of the art chemical tools and imaging strategies for metal ions, redox signaling species, and metabolites in the cell, cellular delivery and targeting approaches, and their application to studying life processes.
Monday, October 5, 2015 | 1:30 PM - 5:30 PM
Speakers: Roger Greenberg (University of Pennsylvania), Andreas Hochwagen (New York University), Megan King (Yale University), Rodney Rothstein (Columbia University)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Thursday, October 15, 2015 | 8:00 AM - 5:00 PM
Speakers: Jonathan Braun (University of CaliforniaLos Angeles), Rudolph Clerval (Enterome), David N. Cook (Seres Health), Stanislav Dusko Ehrlich (King's College London), Michael A. Fischbach (University of California, San Francisco), Andrew Goodman (Yale School of Medicine), Sarkis Mazmanian (California Institute of Technology), Paul O'Toole (University College Cork), R. Balfour Sartor (University of North Carolina School of Medicine)
In the human colon, the microbiome forms one of the densest bacterial ecosystems known in nature. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on gut health.
Friday, October 16, 2015 | 8:30 AM - 5:00 PM
Keynote Speakers: Sonia Angell (New York City Department of Health and Mental Hygiene), Rogan Kersh (Wake Forest University)
Speakers: Eliza Barclay (NPR's Salt), Sanjay Basu (Stanford University), Julia Belluz (VOX), Jason P. Block (Harvard Medical School), Juan Rivera Dommarco (Research Center in Nutrition and Health, National Institutes of Public Health, Mexico), Helena Bottemiller Evich (Politico), Matthew Harding (Duke University), Terry Huang (CUNY School of Public Health), Nancy Huehnergarth (Nancy F. Huehnergarth Consulting), Barbara A. Laraia (Berkeley School of Public Health), Jeff Niederdeppe (Cornell University)
Well-informed nutrition policy decisions which consider scientific evidence should strive for effective policies that improve health outcomes on a large scale. This one-day conference will focus on emerging research methodology, how to interpret research outcomes and how these can be used to inform policy.
October 18 - 22, 2015
Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatkowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Takahiro Maeda (Harvard Cancer Center), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute), Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Scott Reeder (University of Wisconsin School of Medicine and Public Health), Stefano Rivella (Children's Hospital of Philadelphia), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital), Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)
Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.
Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM
Speakers: Andras J. Bauer (Boehringer Ingelheim USA), Alex Huang (Genentech), Michael Jackson (Sanford-Burnham Medical Research Institute), Bryan Laffitte (Genomics Institute of the Novartis Research Foundation), Jonathan A. Lee (Eli Lilly), Lorenz Mayr (AstraZeneca), Friedrich Metzger (F. Hoffmann-La Roche Ltd), Bruce A. Posner (University of Texas, Southwestern Medical Center), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Sue Swalley (Novartis Institutes for Biomedical Research)
This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.
October 27 - December 5, 2015
Course Instructors: Larry Petcovic (Human Workflows), Randall Ribaudo (Human Workflows)
Enhance your communication, leadership, and teambuilding skills that all employers value by taking From Scientist to CSO, one of the most popular courses offered at the New York Academy of Sciences.
Tuesday, July 28, 2015 | 8:30 AM - 6:00 PM
Speakers: Marc D Chioda (Pfizer Inc), Leonard James (Pfizer Inc), Iya Khalil (GNS Healthcare), Michael Matheny (Vanderbilt University), Jason H. Moore (University of Pennsylvania), Nicholas Tatonetti (Columbia University Medical Center), Craig P. Webb (NuMedii, Inc), Chunhua Weng (Columbia University), Diane Wuest (GNS Healthcare)
In the era of precision medicine, analyses of large volumes of data are key to developing targeted and effective therapeutics. This symposium explores how big data and predictive knowledge are used to guide drug development and clinical trials.
Friday, June 19, 2015 | 8:00 AM - 5:30 PM
Speakers: Joel Ackelsberg (NYC Department of Health and Mental Hygiene), Eric Alm (Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology), Martin J. Blaser (New York University Langone Medical Center), Ilana Brito (Massachusetts Institute of Technology), Jane Carlton (New York University Center for Genomics and Systems Biology), Rumi Chunara (New York University Polytechnic School of Engineering), Laurie Garrett (Council on Foreign Relations), Jack Gilbert (Argonne National Laboratory), Jo Handelsman (White House Office of Science and Technology Policy), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), W. Ian Lipkin (Center for Infection and Immunity, Columbia University), Juan Maestre (The University of Texas at Austin), Christopher Mason (Institute for Computational Biomedicine, Weill Cornell Medical College), Paula Olsiewski (Alfred P. Sloan Foundation), Rachel Poretsky (University of Illinois at Chicago), Coby Schal (North Carolina State University Department of Entomology)
Efforts to map all of the genetic information of microbial communities that make up the urban genome—from kiosks and subways, to soil and sewage—seek to improve the health and productivity of the built environments in which we live.
Thursday, June 18, 2015 | 8:00 AM - 5:30 PM
Keynote Speaker: Steve Kay (University of Southern California)
Speakers: Francis J. Doyle III (University of California Santa Barbara), Andrew Ewald, PhD (Johns Hopkins University), Scott E. Fraser (University of Southern California), Peter Kuhn (University of Southern California), Christopher E. Mason (Weill Cornell Medical College), Paul Newton (University of Southern California), Amanda Randles (Harvard University), Chris Sander (Memorial Sloan Kettering Cancer Center)
Quantitative Biology: From Molecules to Man will bring together professionals in science, medicine, and engineering to articulate a vision for the future of improving patient health outcomes.
June 15 - August 10, 2015
Take the online course "Scientists Teaching Science" and learn about active vs. passive learning, creating course objectives and test items, and finding ways to improve your teaching and assessment techniques for students of all ages.
Thursday, June 11, 2015 | 8:45 AM - 5:15 PM
Keynote Speaker: Jane A. Driver (Brigham and Women's Hospital)
Speakers: Kurt Brunden (University of Pennsylvania), Stuart Calderwood (Harvard Medical School), Gary Landreth (Case Western Reserve University), Tamara Maes, PhD (Oryzon Genomics S.A.), David M. Roy (Memorial Sloan Kettering Cancer Center), Stephen Strittmatter (Yale University School of Medicine), Li Huei Tsai (Massachusetts Institute of Technology), Raymond Scott Turner (Georgetown University), Claes Wahlestedt (University of Miami Miller School of Medicine), Hui Zheng (Baylor College of Medicine)
Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegenerative diseases? This meeting will address these questions to help advance therapeutic development.
How does a bright young scientist become an entrepreneur and venture capital investor? Learn how Jorge M. Torres used his scientific background to help launch a career as a venture capital investor.
Interested in working as a Medical Science Liaison (MSL)? Dr. Arati Sadalge Kreibich discusses her work as an MSL and provides advice on how you can transition from the bench and into MSL positions.
Interested in starting your own company? Listen to Dr. Joshua Spodek discusses his exciting path from a PhD in physics to a career as entrepreneur.
Interested in working in science and international policy? Dr. Dana Perkins discusses her extensive career in government and provides advice on how you can transition from the bench and into the exciting world of policy.
Interested in promoting the next generation of researchers through innovative education initiatives? Dr. Oscar Pineda-Catalan, Manager of the American Museum of Natural History's Science Research Mentoring Program, discusses the importance of engaging youth in science education and how to develop skills to be an effective educator and mentor that can help young professionals to develop alternative careers in science.
Are you interested in informal science programs? Do you want to help create a larger science community? Dr. Jeanne Garbarino, Director of Science Outreach at The Rockefeller University, explains how her interest in science communication—via blogging, social media and research programs—has helped her reach new audiences.
Dream of independence and your own company? Human Workflows and SciPhD co-founder Randy Ribaudo discusses the rewards and challenges of entrepreneurship, and how scientists can apply their problem-solving skills—and improve their communication skills—to successfully start and run a business.
Interested in the business of science or how research programs get designed, funded, and managed? Hear Mike Holland discuss how he went from imaging aluminum uptake in soybean roots to overseeing multi-billion dollar federal research programs.
Interested in translating your science critical thinking skills to the market? Listen to Caroline Corner describe how she left the lab bench to break into the finance industry as an equity research analyst and consultant.
Want to learn more about consulting? Hear Jeremy Buzzard, a PhD in molecular and cellular biology, talk about his career in management consulting as a partner at McKinsey & Co.
Not ready to leave the bench after grad school? Find out how training in an industry lab versus an academic lab compares from Justin Hall, currently a postdoctoral fellow at Pfizer.
Intrigued by the forensic scientists on shows like CSI? Find out what the job's really like from criminalist Craig O'Connor, who joined the Office of Chief Medical Examiner in NYC after earning a PhD in genetics.
If you're thinking about a career in academia, find out how Rachel O'Neill transitioned from her postdoc to a faculty position, as well as the benefits and challenges of this path.
Hear Laura Malisheski discuss how she transitioned from her postdoc in neuroscience to advising others on their career paths.
If working with scientists to patent their inventions sounds appealing, hear Ryan Murphey talk about how you can get into intellectual property law with a PhD.
For those with a passion for communicating science: Beth Schachter details her journey as an assistant professor who left the bench to pursue a career in science communications.
If teaching is your calling, tune in to Ellen Cohn, an immunologist, talk about her transition into teaching middle school science.
Want to be a journal editor? Listen to Brooke Grindlinger discuss her path from being a PhD in microbiology to an editor at the Journal of Clinical Investigation.
Interested in publishing? Hear Jennifer Henry discuss how she went from studying plant molecular biology to being a publishing manager at Nature.
Organizers: Lydia Finley (Memorial Sloan-Kettering Cancer Center), Steven S. Gross (Weill Cornell Medical College), Costas A. Lyssiotis (Weill Cornell Medical College), and Sonya Dougal (The New York Academy of Sciences)
Keynote Speaker: Craig B. Thompson (Memorial Sloan-Kettering Cancer Center)
There is resurgent interest in cancer cell metabolism as researchers seek to understand how metabolic pathways are altered in cancer and how these alterations can be exploited for therapeutic gain. This eBriefing discusses advances in the field.
Edited by Annals of the New York Academy of Sciences
Reports on early-life influences on obesity; food safety considerations for innovative nutrition solutions; and a multifaceted cytokine that functions in both angiogenesis and inflammation
Keynote Speakers: Christopher Dye (World Health Organization) and Elisabet Lindgren (Stockholm University, Sweden)
This eBriefing explores health risks associated with climate change and strategies for adapting to its effects.
Organizers: Nathalie Breysse (Lundbeck Research USA), Elena Dale (Lundbeck Research USA), and Sonya Dougal (The New York Academy of Sciences)
Non-motor symptoms are common but often overlooked in Parkinson's disease. This eBriefing examines new approaches to studying disease mechanisms, which could lead to a better understanding of pathogenesis and to the development of new therapies.
Keynote Speaker: Frank Hu (Harvard T.H. Chan School of Public Health)
This eBriefing explores research on metabolic health from several disciplines and looks at how different types of data combine to explain physiology and disease.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
January 5, 2010
New York Governor David Paterson has set a target of reducing greenhouse gas emissions in the state by 80% by the year 2050. Stakeholders met at the Academy to discuss strategies for reaching this goal.